Ghazi, N. G., Kirk, T. Q., Knape, R. M., & al, e. (2010). Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration? Dove Medical Press.
Style de citation Chicago (17e éd.)Ghazi, Nicola G., Tyler Q. Kirk, Robert M. Knape, et et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.
Style de citation MLA (8e éd.)Ghazi, Nicola G., et al. Is Monthly Retreatment with Intravitreal Bevacizumab (Avastin®) Necessary in Neovascular Age-related Macular Degeneration? Dove Medical Press, 2010.
Attention : ces citations peuvent ne pas être correctes à 100%.